Caxton Associates (New York)’s Brink's BCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$2.29M Buy
24,642
+7,690
+45% +$769K 0.07% 88
2024
Q3
$1.96M Buy
+16,952
New +$1.79M 0.07% 124
2024
Q2
Sell
-33,930
Closed -$3.13M 482
2024
Q1
$3.13M Buy
+33,930
New +$2.82M 0.18% 74
2018
Q1
Sell
-3,800
Closed -$299K 327
2017
Q4
$299K Buy
+3,800
New +$308K 0.01% 315

Other funds holding BCO

Caxton Associates (New York)'s BCO Position: Q4 2024 in Review

Caxton Associates (New York) increased its Brink's (BCO) stake by 45% in Q4 2024, buying an estimated $769K and bringing the position to 24,642 shares worth $2.29M. The position accounts for 0.07% of the portfolio, ranked #88.

Caxton Associates (New York) first reported a position in BCO in Q4 2017 and has held it in 4 quarters since. The position peaked at $3.13M in Q1 2024. 300 funds tracked by Wall St. Rank hold BCO as of Q4 2024.

  • Caxton Associates (New York) held 24,642 shares of Brink's worth $2.29M as of Q4 2024.
  • Caxton Associates (New York) bought 7,690 Brink's shares in Q4 2024, an estimated $769K.
  • Brink's made up 0.07% of Caxton Associates (New York)'s portfolio in Q4 2024, its #88 holding.
  • Caxton Associates (New York) first reported a position in Brink's in Q4 2017 and has held it in 4 quarters since.
  • Caxton Associates (New York)'s Brink's position peaked at $3.13M in Q1 2024.
  • 300 funds tracked by Wall St. Rank held Brink's as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.